DOI QR코드

DOI QR Code

Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I

  • Lim, Chae Jin ;
  • Jeon, Jung Eun ;
  • Jeong, Se Kyoo ;
  • Yoon, Seok Jeong ;
  • Kwon, Seon Deok ;
  • Lim, Jina ;
  • Park, Keedon ;
  • Kim, Dae Yong ;
  • Ahn, Jeong Keun ;
  • Kim, Bong-Woo
  • Received : 2014.12.04
  • Accepted : 2015.01.22
  • Published : 2015.06.30

Abstract

Based on the potential beneficial effects of growth hormone releasing peptide (GHRP)-6 on muscle functions, a newly synthesized GHRP-6-biotin conjugate was tested on cultured myoblast cells. Increased expression of myogenic marker proteins was observed in GHRP-6-biotin conjugate-treated cells. Additionally, increased expression levels of insulin-like growth factor-1 and collagen type I were observed. Furthermore, GHRP-6-biotin conjugate-treated cells showed increased metabolic activity, as indicated by increased concentrations of energy metabolites, such as ATP and lactate, and increased enzymatic activity of lactate dehydrogenase and creatine kinase. Finally, binding protein analysis suggested few candidate proteins, including desmin, actin, and zinc finger protein 691 as potential targets for GHRP6-biotin conjugate action. These results suggest that the newly synthesized GHRP-6-biotin conjugate has myogenic stimulating activity through, at least in part, by stimulating collagen type I synthesis and several key proteins. Practical applications of the GHRP-6-biotin conjugate could include improving muscle condition. [BMB Reports 2015; 48(9): 501-506]

Keywords

Biotin;Collagen;Growth-hormone releasing peptide;Insulin-like growth factor;Myogenesis

References

  1. Paulin D and Li Z (2004) Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 301, 1-7 https://doi.org/10.1016/j.yexcr.2004.08.004
  2. Li Z, Mericskay M, Agbulut O et al (1997) Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 139, 129-144 https://doi.org/10.1083/jcb.139.1.129
  3. Li H, Choudhary SK, Milner DJ, Munir MI, Kuisk IR and Capetanaki Y (1994) Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol 124, 827-841 https://doi.org/10.1083/jcb.124.5.827
  4. Lokireddy S, Wijesoma IW, Sze SK, McFarlane C, Kambadur R and Sharma M (2012) Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. Am J Physiol Cell Physiol 303, C512-529 https://doi.org/10.1152/ajpcell.00402.2011
  5. Cohen S, Zhai B, Gygi SP and Goldberg AL (2012) Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J Cell Biol 198, 575-589 https://doi.org/10.1083/jcb.201110067
  6. Hong J, Kim BW, Choo HJ et al (2014) Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation. J Biol Chem 289, 20012-20025 https://doi.org/10.1074/jbc.M114.560078
  7. Kim BW, Lee JW, Choo HJ et al (2010) Mitochondrial oxidative phosphorylation system is recruited to detergent-resistant lipid rafts during myogenesis. Proteomics 10, 2498-2515 https://doi.org/10.1002/pmic.200900826
  8. Asakura A, Komaki M and Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245-253 https://doi.org/10.1046/j.1432-0436.2001.680412.x
  9. Florini JR, Ewton DZ and Magri KA (1991) Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 53, 201-216 https://doi.org/10.1146/annurev.ph.53.030191.001221
  10. Lee CS, Yi JS, Jung SY et al (2010) TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell Death Differ 17, 1254-1265 https://doi.org/10.1038/cdd.2010.1
  11. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J and Chowen JA (2002) Growth hormone (GH) and GH-re- leasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143, 4113-4122 https://doi.org/10.1210/en.2002-220261
  12. Frago LM, Paneda C, Argente J and Chowen JA (2005) Growth hormone-releasing peptide-6 increases insulinlike growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones. J Neuroendocrinol 17, 701-710 https://doi.org/10.1111/j.1365-2826.2005.01347.x
  13. Zhou S, Salisbury J, Preedy VR and Emery PW (2013) Increased collagen synthesis rate during wound healing in muscle. PLoS One 8, e58324 https://doi.org/10.1371/journal.pone.0058324
  14. Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D and Bressan GM (1998) Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet 7, 2135-2140 https://doi.org/10.1093/hmg/7.13.2135
  15. Takano H, Komuro I, Oka T et al (1998) The Rho family G proteins play a critical role in muscle differentiation. Mol Cell Biol 18, 1580-1589 https://doi.org/10.1128/MCB.18.3.1580
  16. Schwander M, Leu M, Stumm M et al (2003) Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell 4, 673-685 https://doi.org/10.1016/S1534-5807(03)00118-7
  17. Yi JS, Park JS, Ham YM et al (2013) MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun 4, 2354 https://doi.org/10.1038/ncomms3354
  18. Paneda C, Arroba AI, Frago LM et al (2003) Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats. Neuroreport 14, 1633-1635 https://doi.org/10.1097/00001756-200308260-00018
  19. Smith RG (2005) Development of growth hormone secretagogues. Endocr Rev 26, 346-360 https://doi.org/10.1210/er.2004-0019
  20. Granado M, Garcia-Caceres C, Tuda M, Frago LM, Chowen JA and Argente J (2011) Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats. Mol Cell Endocrinol 337, 101-113 https://doi.org/10.1016/j.mce.2011.02.002
  21. Berlanga J, Cibrian D, Guevara L et al (2007) Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. Clin Sci (Lond) 112, 241-250 https://doi.org/10.1042/CS20060103
  22. Pontiroli AE (1998) Peptide hormones: Review of current and emerging uses by nasal delivery. Adv Drug Deliv Rev 29, 81-87 https://doi.org/10.1016/S0169-409X(97)00062-8
  23. Fleisher D, Niemiec SM, Oh CK, Hu Z, Ramachandran C and Weiner N (1995) Topical delivery of growth hormone releasing peptide using liposomal systems: an in vitro study using hairless mouse skin. Life Sci 57, 1293-1297 https://doi.org/10.1016/0024-3205(95)02086-X
  24. Charge SB and Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84, 209-238 https://doi.org/10.1152/physrev.00019.2003
  25. Smith CK, 2nd, Janney MJ and Allen RE (1994) Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol 159, 379-385 https://doi.org/10.1002/jcp.1041590222
  26. Makrantonaki E, Schonknecht P, Hossini AM et al (2010) Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol 45, 801-813 https://doi.org/10.1016/j.exger.2010.08.005
  27. Zouboulis CC and Makrantonaki E (2012) Hormonal therapy of intrinsic aging. Rejuvenation Res 15, 302-312 https://doi.org/10.1089/rej.2011.1249
  28. DeVita RJ (1997) Small molecule mimetics of GHRP-6. Expert Opin Investig Drugs 6, 1839-1843 https://doi.org/10.1517/13543784.6.12.1839
  29. Micic D, Casabiell X, Gualillo O, Pombo M, Dieguez C and Casanueva FF (1999) Growth hormone secretagogues: the clinical future. Horm Res 51 Suppl 3, 29-33 https://doi.org/10.1159/000053159
  30. Makrantonaki E, Zouboulis CC and German National Genome Research N (2007) The skin as a mirror of the aging process in the human organism--state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 42, 879-886 https://doi.org/10.1016/j.exger.2007.07.002
  31. Florini JR, Ewton DZ and Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17, 481-517

Cited by

  1. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects vol.11, 2017, https://doi.org/10.1177/1179546817694558
  2. Identification of amino acids related to catalytic function of Sulfolobus solfataricus P1 carboxylesterase by site-directed mutagenesis and molecular modeling vol.49, pp.6, 2016, https://doi.org/10.5483/BMBRep.2016.49.6.077